Abstract Data Envelopment Analysis (DEA), Multi-criteria Decision Analysis (MCDA), and
Cluster Analysis (CA) are techniques widely used to help decision-makers determine the …

While changes in RNA splicing have been extensively studied in hepatocellular carcinoma
(HCC), no studies have systematically investigated changes in RNA splicing during earlier …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Serine‐
arginine rich splicing factor 3 (SRSF3) plays a critical role in hepatocyte function and its loss …

The mammalian cleavage factor I (CFIm) has been implicated in alternative polyadenylation
(APA) in a broad range of contexts, from cancers to learning deficits and parasite infections …

Background Hepatocellular carcinoma (HCC) ranks the sixth prevalent tumors with high
mortality globally. Alternative splicing (AS) drives protein diversity, the imbalance of which …

Background Triple-negative breast cancer (TNBC) is widely concerning because of high
malignancy and poor prognosis. There is increasing evidence that alternative splicing (AS) …

Hepatitis C virus-associated HCC (HCV-HCC) is a prevalent malignancy worldwide and the
molecular mechanisms are still elusive. Here, we screened 240 differentially expressed …

Background Alternative splicing (AS) is a critical mechanism of post-transcriptional
regulation and has been widely reported to be associated with the tumor progression and …

Background: Hepatocellular carcinoma (HCC) is a lethal disease with high relapse and
dismal survival rates. Alternative splicing (AS) plays a crucial role in tumor progression …

A splicing factor is as an important upstream regulator of the alternative splicing process.
Hence, it is considered to be a therapeutic target for hepatocellular carcinoma (HCC) …